Type 1 diabetes mellitus
Conditions
Interventions
This is a randomized, crossover clinical trial, where all participants (n=20) will perform all interventions, thus not having a control group
the study will consist of 7 arms, being them, traditional resistance exercise A (60% of 1RM), traditional resistance exercise B (80% of 1RM), circuit resistance exercise (60% of 1RM) and circuit resis
there will be no masking. In the first stage, resistance exercise sessions will be held
the sessions will be randomized between the 4 possibilities (Traditional resistance exercise A or B or Circuit resistance exercise A or B). All resistance exercise sessions will consist of the exercis
the adopted cadence will be 1.5 seconds for each phase of the movement. The traditional resistance training session A will be performed at 60% of 1 RM. With 3 sets x 10 repetitions, 60 seconds of rest
the total session time will be 36 minutes. The traditional resistance training session B will be performed at 80% of 1 RM. With 3 sets x 10 repetitions, 60 seconds of rest between sets and 60 seconds
the total session time will be 36 minutes. The resistance exercise session in circuit A will consist of 3 sets x 10 repetitions at 60% of 1 RM (all exercises will be done in sequence) and with 120 sec
the total session time will be 16 minutes. The resistance exercise session in circuit B will consist of 3 sets x 10 re
G11.427.410.698.277
Sponsors
Instituto Mantenedor de Ensino Superior da Bahia
Centro Universitário de Excelência - UNEX
Eligibility
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Volunteers with type I or type II diabetes mellitus, female or male; age between 18 to 45 years
Exclusion criteria
Exclusion criteria: Volunteers who have neuropathy developed by diabetes, a history of alcohol or drug abuse; diagnoses of cardiac, renal, gastrointestinal, hepatic, pulmonary, neurological, psychiatric, hematological or metabolic pathologies; suffer some type of muscle injury that prevents the practice of physical exercises; individuals who during the research period fail to show up for physical tests or exercise sessions and who are not available for a new day/time to perform the procedures; who have medical restrictions for the practice of physical exercise or any type of secondary disease that may be aggravated due to participation in the research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find, at the end of the interventions, a decrease in capillary blood glucose (mg·dL-1), which will be collected using a clinical glucometer (Accu-Check Active, Roche, Brazil), disposable reagent strips and lancets (Accu-Check Active, Roche, Brazil). Check Softclix, Roche, Brazil). | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to find, at the end of the interventions, improvements in the lipid profile, verified by lipidogram, in order to verify the amount of total cholesterol, HDL cholesterol, triglycerides (TG) and LDL cholesterol; improvement in cardiovascular parameters, verified by maximal effort test; improvement in psychophysiological parameters verified by the OMNI-RES scales (for resistance exercise), BORG scale (for aerobic exercises) and affective perception measured from the visual analogue scale of pleasure. | — |
Countries
Brazil
Contacts
Public ContactLeandro Carvalho
Instituto Mantenedor de Ensino Superior da Bahia
Outcome results
None listed